HIV Drug Descovy May Increase Risk of High Blood Pressure: Study
Kaiser Permanente researchers warn that the side effects of Descovy could result in an increased risk of hypertension and the need for cholesterol control.
Kaiser Permanente researchers warn that the side effects of Descovy could result in an increased risk of hypertension and the need for cholesterol control.
A California appeals court is weighing whether Gilead had a responsibility to develop safer HIV drugs to replace older ones with a higher risk of kidney damage and bone fractures.
Nearly 20 plaintiffs have filed a lawsuit against Gilead, saying it failed to warn patients its TDF-based HIV drugs could cause bone and kidney problems.
A lawsuit filed by two different plaintiffs say they suffered bone density loss due to the side effects of Gilead TDF-based HIV drugs.
A lawsuit filed by 20 plaintiffs claims Gilead held back safer formulations of its HIV drugs in order to maximize profits at the expense of their kidneys and other health…
Gilead knew its HIV drugs carried severe health risks before the first ones were placed on the market, the lawsuit claims.
One drug manufacturer has agreed to pay $10 million to resolve its part in allegations that Gilead and other drug makers conspired to keep HIV medication prices artificially high.
A Gilead TDF lawsuit involving about 80 plaintiffs alleges the drug maker exposed patients unnecessarily to toxic effects of its HIV drugs when it had a safer formulation available.
A group of plaintiffs have filed a joint lawsuit against Gilead, claiming it purposefully misled doctors and consumers about the safety of its HIV drugs in order to maximize profits…
A U.S. District Judge has cleared the way for an HIV drug lawsuit to proceed against Gilead, saying the company's actions in how it marketed and sold drugs like Truvada…